The Federal Trade Commission has actually challenged more than 100 patents drugmakers noted in the FDA’s “Orange Book,” which secures them from generic competitors. Amongst these are patents for Mylan’s….
NEW YORK CITY (Reuters) -Drugmakers consisting of Pfizer, Sanofi and Takeda Pharmaceutical strategy to raise rates in the United States on more than 500 drugs in early January, according to….